The potential performance of certain photonuclear target systems designed to produce short-lived positron emitters for nuclear medicine applications was evaluated. Included were calculations of photonuclear target activity yields, relative radiolysis product yields and relative specific activities of products as a function of photonuclear target shapes, dimensions, spacing from the bremsstrahlung photon source, and the energy of the electron beam using the reactions 12C(gamma,n)11C, 14N(gamma,n)13N, and 16O(gamma,n)15O. Results indicate that substantial activity yields can be achieved in these photonuclear target systems and that specific activity of the product varies widely as a function of the energy of the electron beam used to produce the bremsstrahlung and the included angle from the central beam axis that the photonuclear target occupies. Results indicate that several commercial radiotherapy accelerators appear to have electron beam energy and current capabilities suitable for producing multiple mCi (1 mCi = 3.7 X 10(7) Bq) amounts of the above radionuclides.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1118/1.596141 | DOI Listing |
Eur Phys J C Part Fields
November 2024
Department of Physics, University of Jyvaskyla, P.O. Box 35, Fl-40014 Jyvaskyla, Finland.
Appl Radiat Isot
December 2024
NSC Kharkov Institute of Physics and Technology, National Academy of Sciences of Ukraine, Kharkiv, Ukraine.
Based on analytical description of isotope production by bremsstrahlung (X-ray) radiation, an algorithm is proposed for calculating the optimal dimensions of a cylindrical target of given mass positioned at a given distance from a bremsstrahlung converter to ensure the maximum yield of the isotope product. The expressions are derived for the total activity and its distribution along the target axis. A technique of γ-spectrometric measuring the activity of a thick production target is proposed.
View Article and Find Full Text PDFNucl Med Biol
September 2024
Westinghouse Electric Company LLC, 1000 Westinghouse Drive, Cranberry Township, PA 16066, United States of America.
Background: Actinium-225 is one of the most promising radionuclides for targeted alpha therapy. Its limited availability significantly restricts clinical trials and potential applications of Ac-based radiopharmaceuticals.
Methods: In this work, we examine the possibility of Ac production from the thermal neutron flux of a nuclear reactor.
Phys Rev Lett
May 2024
INFN, Sezione di Pavia, Pavia, Italy.
K^{+}K^{-} pairs may be produced in photonuclear collisions, either from the decays of photoproduced ϕ(1020) mesons or directly as nonresonant K^{+}K^{-} pairs. Measurements of K^{+}K^{-} photoproduction probe the couplings between the ϕ(1020) and charged kaons with photons and nuclear targets. The kaon-proton scattering occurs at energies far above those available elsewhere.
View Article and Find Full Text PDFPhys Med Biol
May 2024
Department of Radiation Oncology, University of California San Francisco, San Francisco CA, United States of America.
. We provide optimal particle split numbers for speeding up TOPAS Monte Carlo simulations of linear accelerator (linac) treatment heads while maintaining accuracy. In addition, we provide a new TOPAS physics module for simulating photoneutron production and transport.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!